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Hypoxia Modulates Cholinergic but Not Opioid Activation
of G Proteins in Rat Hippocampus
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ABSTRACT: Intermittent hypoxia, such as that associated with ob-
structive sleep apnea, can cause neuronal death and neurobehavioral
dysfunction. The cellular and molecular mechanisms through which hy-
poxia alter hippocampal function are incompletely understood. This
study used in vitro [35S]guanylyl-50-O-(c-thio)-triphosphate ([35S]GTPcS)
autoradiography to test the hypothesis that carbachol and DAMGO acti-
vate hippocampal G proteins. In addition, this study tested the hypothe-
sis that in vivo exposure to different oxygen (O2) concentrations causes
a differential activation of G proteins in the CA1, CA3, and dentate
gyrus (DG) regions of the hippocampus. G protein activation was quan-
tified as nCi/g tissue in CA1, CA3, and DG from rats housed for 14 days
under one of three different oxygen conditions: normoxic (21% O2)
room air, or hypoxia (10% O2) that was intermittent or sustained.
Across all regions of the hippocampus, activation of G proteins by the
cholinergic agonist carbachol and the mu opioid agonist [D-Ala2, N-
Met-Phe4, Gly5] enkephalin (DAMGO) was ordered by the degree of hy-
poxia such that sustained hypoxia > intermittent hypoxia > room air.
Carbachol increased G protein activation during sustained hypoxia
(38%), intermittent hypoxia (29%), and room air (27%). DAMGO also
activated G proteins during sustained hypoxia (52%), intermittent hy-
poxia (48%), and room air (43%). Region-specific comparisons of G
protein activation revealed that the DG showed significantly less activa-
tion by carbachol following intermittent hypoxia and sustained hypoxia
than the CA1. Considered together, the results suggest the potential for
hypoxia to alter hippocampal function by blunting the cholinergic acti-
vation of G proteins within the DG. VC 2007 Wiley-Liss, Inc.
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INTRODUCTION
Obstructive sleep apnea (OSA) is characterized by repeated obstruc-
tion of the upper airway during sleep and results in episodes of intermit-
tent hypoxia and sleep fragmentation (Ryan and Bradley, 2005). An esti-
mated 12–18 million people in the United States have sleep apnea, with
a higher prevalence in men (4%) than in women (2%) and OSA is asso-
ciated with risk factors such as age, excessive weight, and high blood
pressure (Young et al., 1993). In OSA patients, hypoxic events can occur
20–30 times per hour with cessation of breathing last-
ing for 10–20 s or more (Shamsuzzaman et al., 2003).
Daytime symptoms of OSA include excessive sleepiness
and neurobehavioral impairment (Engleman and Joffe,
1999; Beebe, 2005; Walker and Stickgold, 2006).
Research concerning the effects of intermittent hypoxia
has been stimulated by efforts to understand the impact of
hypoxia on sleep, learning, and memory (Ninomiya et al.,
1989; Greenberg et al., 1999; Gozal et al., 2001a; Ham-
rahi et al., 2001; Gozal et al., 2002; Goldbart et al.,
2003a,b; Row et al., 2003; Zhao et al., 2005).
The hippocampus is vulnerable to hypoxia (Yamaoka
et al., 1993; Matsuoka et al., 1997; Gozal et al.,
2001a,b) and intermittent hypoxia alters the excitability
of hippocampal neurons (Schiff and Somjen, 1985).
Cholinergic neurotransmission contributes to hippo-
campal function (Colom et al., 1991), and muscarinic
cholinergic receptors are expressed by hippocampal
neurons (Satoh and Kaneko, 1994; Rouse et al., 1999;
van der Zee and Luiten, 1999). Muscarinic cholinergic
receptors are G protein coupled (reviewed in Caulfield
and Birdsall, 1998), and carbachol activates muscarinic
cholinergic receptors and G proteins in brain regions
regulating sleep (Capece et al., 1998a; DeMarco et al.,
2003; Douglas et al., 2004). Activated G proteins can
be labeled using [35S]guanylyl-50-O-(g-thio)-triphos-
phate ([35S]GTPgS) (Sim et al., 1995). The hippocam-
pus also contains endogenous opioids (Watson et al.,
1982) and mu opioid receptors (Crain et al., 1986;
Mansour et al., 1987; Tempel and Zukin, 1987; Drake
and Milner, 2002). Mu opioid receptors are coupled to
G proteins (Corbett et al., 2006), providing a key ra-
tionale for the present use of the mu opioid receptor
agonist [D-Ala2, N-Met-Phe4, Gly5] enkephalin
(DAMGO). G proteins in brain regions regulating
sleep are activated by DAMGO (Capece et al., 1998b;
Tanase et al., 2001; Bernard et al., 2006). Many studies
have shown that activating mu opioid receptors can
have excitatory actions throughout the hippocampus
(Zieglgansberger et al., 1979; Dunwiddie et al., 1980;
Siggins and Zieglgansberger, 1981; Mayer et al., 1994;
Mayer and Henriksen, 1995). Hippocampal mu opioid
receptors have a region-specific distribution and con-
tribute to normal hippocampal function (Svodoba
et al., 1999; Drake and Milner, 2002).
No previous studies have quantified the effect of hy-
poxia on cholinergic or opioid activation of G proteins
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in rat hippocampus. Therefore, the present study was designed to
test the hypothesis that carbachol and DAMGO activate hippo-
campal G proteins. In addition, this study tested the hypothesis
that these changes in G protein activation are modulated by differ-
ent hypoxic treatments (intermittent and sustained hypoxia) in
the CA1, CA3, and dentate gyrus (DG) regions of the hippocam-
pus. Portions of these results have been presented in abstract form
(Hambrecht et al., 2006).
MATERIALS AND METHODS
Overview of Study Design
During 14 days of in vivo treatment, rats were exposed to
either room air, intermittent hypoxia, or sustained hypoxia. On
protocol day 15, rats in all three groups were decapitated and
brains were removed and frozen for a subsequent biochemical
assay that makes it possible to quantify agonist-stimulated G
protein activation in a brain region-specific manner (Sim et al.,
1995, 1997; Harrison and Traynor, 2003). This in vitro assay
(described below) focused on G proteins in the CA1, CA3,
and DG regions of the hippocampus. Brain sections were
assayed for G protein activation using in vitro conditions
that quantified basal, carbachol- and DAMGO-stimulated
[35S]GTPgS binding. Figure 1A provides a schematic over-
view of the study design.
Animals and In Vivo Treatment
All experiments were conducted in accordance with the
Public Health Service policy on Humane Care and Use of
FIGURE 1. Schematic of study design and techniques used to
quantify G protein activation in the hippocampus. (A) Outlines
the in vivo and in vitro phases of this study. During the initial in
vivo phase, rats underwent one of the three treatments involving
14 days of exposure to room air, intermittent hypoxia, or sustained
hypoxia. For the following in vitro phase of the study, rats were
decapitated and brains were removed and immediately frozen.
Brains were sectioned serially and the hippocampus was assayed
for G protein activation by the cholinergic agonist carbachol and
the mu opioid receptor agonist DAMGO. Basal levels of
[35S]GTPcS binding (no agonist used) following 14 days of hous-
ing in room air served as the control condition. The number of
animals (n) is shown for each in vivo condition. (B, C) Schematic
of the technique for obtaining region-specific measures of hippo-
campal [35S]GTPcS binding. (B) Digitized image of a cresyl vio-
let-stained tissue section containing hippocampal measurement
sites. (C) Digitized image of an autoradiogram in which optical
density in the hippocampus was proportional to G protein activa-
tion quantified by the amount of [35S]GTPcS binding. The auto-
radiogram in (C) was created from the tissue section shown in
(B). The circles on the hippocampus (B) indicate the locations
that were transferred from the cresyl violet-stained section to the
autoradiogram (C) for measuring [35S]GTPcS binding in nCi/g
tissue.
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Laboratory Animals (National Institutes of Health Publication
80-23). Before starting the experiment, groups of up to 6
adult male Sprague-Dawley rats (Charles River Laboratories,
Wilmington, MA), 45–50 days old, were housed in identical
chambers (30 3 20 3 20 cubic in) under normoxic condi-
tions and in a 12:12 h light-dark cycle (lights on at 6:00
A.M.). Ambient temperature was maintained at 22–248C. Air
circulation for each chamber was set at 60 L/min, resulting in
one complete air turnover every 10 s. To begin an experi-
ment, rats were exposed for 14 days to one of three different
O2 concentrations, as described previously (Gozal et al.,
2001a). O2 concentration was monitored throughout the
entire experiment and adjusted automatically if necessary. The
intermittent hypoxia group (n 5 6) experienced alternating
10% O2 and 21% O2 every 90 s for 12 h during the light
phase, and room air for 12 h during the dark phase. Rats in
the sustained hypoxia group (n 5 5) were exposed to hypoxic
air (10% O2) throughout the 12 h of the light phase, and
room air during the dark phase. Control animals (n 5 6)
were exposed to normoxic (21% O2) room air 24 h per day.
After 14 days animals were decapitated and brains were
removed and frozen in a 2308C bilayer of bromobutane
(Fisher Scientific, Boston, MA) and isopentane (Sigma-
Aldrich, St. Louis, MO) to prevent distortion. The favorable
homology of this rodent model of sleep disordered breathing
has been validated (Gozal et al., 2001a; Hamrahi et al.,
2001).
Tissue Preparation and In Vitro [35S]GTPcS
Autoradiography
Coronal brain sections (20 lm) that included the hippocam-
pus (bregma 22.30 to 24.30 mm) (Paxinos and Watson,
1998) were cut serially using a Leica CM 3050 S cryostat
(Leica Microsystems, Nussloch, Germany). Adjacent pairs of
sections were thaw-mounted on gelatin-coated glass slides. The
slides were dried in a vacuum desiccator (48C) and stored in a
2808C freezer until used in the [35S]GTPgS assay.
Guanosine 50-O-(g-thio) triphosphate (GTPgS), guanosine
50-diphosphate (GDP), carbachol, DAMGO, and chemicals
used for buffers were purchased from Sigma-Aldrich (St. Louis,
MO). Perkin Elmer Life Science (Boston, MA) supplied the
[35S]GTPgS. Adenosine deaminase (ADA) was provided by
Roche Applied Science (Indianapolis, IN). The [35S]GTPgS
binding assay was performed as previously described (DeMarco
et al., 2003; Douglas et al., 2004). Slide mounted brain sec-
tions were removed from the freezer and slowly brought to
room temperature. All tissue sections were rinsed in assay
buffer (50 mM Tris-HCl, 3 mM MgCl2, 0.2 mM EGTA, and
100 mM NaCl, pH 7.4) for 10 min. All sections were preincu-
bated for 15 min in a solution containing assay buffer, 2 mM
GDP, and 2 U/mg ADA. One group of tissue sections was
then incubated for 2 h in assay buffer containing 0.04 nM
[35S]GTPgS, 2 mM GDP, 2 U/mg ADA, and the cholinergic
agonist carbachol (1 mM). Basal binding was measured in the
absence of carbachol using a second group of tissue sections. A
third set of tissue sections was incubated in assay buffer con-
taining the mu opioid agonist DAMGO (3 lM). Excess unla-
beled GTPgS (10 lM) was used with a fourth group of brain
sections to evaluate nonspecific binding. Incubation was termi-
nated by rinsing the sections twice in ice-cold 50 mM Tris-
HCl buffer (pH 7.0) for 2 min and once in deionized ice-cold
water for 30 s. Tissue sections then were dried at 48C under a
stream of air. Sections were placed in a vacuum desiccator at
room temperature overnight to complete the drying process.
Sections and 14C microscale standards (31-883 nCi/g, Amer-
sham Biosciences, Arlington Heights, IL) were packed in auto-
radiography cassettes containing Kodak BioMax MR film
(Fisher Scientific, Boston, MA). The film was exposed for 16 h
to the slide-mounted tissue sections and radioactive standards
before being developed using a Kodak X-OMAT Model 2002A
film processor. Tissue sections were fixed with paraformalde-
hyde vapor (808C) and stained with cresyl violet.
Quantification of [35S]GTPcS Binding
The assay described earlier produced autoradiographic images
of hippocampal sections from each of the 17 brains studied. As
a result of the exchange with GDP, the nonhydrolyzable
[35S]GTPgS remained bound to the receptor-G protein com-
plex. Thus, the increase in radioactivity and corresponding
increase in optical density provided a quantitative index of G
protein activation (Sim et al., 1995; Harrison and Traynor,
2003). The autoradiographic images and the cresyl violet-
stained tissue sections from which they were derived were
digitized using a Cohu CCD camera with a Nikon 60 mm
objective. The digitized images were analyzed using a G3 Mac-
intosh computer running the Scion Image 1.62c version of the
NIH Image program. Figures 1B,C illustrate the procedure for
accurately localizing each hippocampal region (CA1, CA3, and
DG) on a digitized image of a cresyl violet-stained tissue sec-
tion. The x-y coordinates of the localized region were then
transferred to the corresponding autoradiographic image, from
which the optical density measurements were made. These
measurements represent total binding. Nonspecific binding val-
ues were obtained in the same manner. Specific [35S]GTPgS
binding values were calculated by subtracting mean nonspeci-
fic binding values for each hippocampal region from the total
binding values for that region. Specific [35S]GTPgS binding
values were expressed as nCi/g tissue.
The present results summarize 9,180 data points of the type
illustrated in Figure 1C. As previously described (Capece et al.,
1998a; DeMarco et al., 2003; Douglas et al., 2004) the data
were averaged to provide a mean for each animal, then aver-
aged across animals for statistical comparisons. This statistically
conservative approach circumvents issues of pseudo-replication
and inflated degrees of freedom. The animal mean data were
analyzed using repeated measures analysis of variance
(ANOVA) and non-parametric Kruskal-Wallis test. Post-hoc
comparisons were performed using Tukey-Kramer multiple
comparisons test and t-test. A probability value of P  0.05
was set as statistically significant.
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RESULTS
Cholinergic- and Opioid-Stimulated G Protein
Activation
Color-coded autoradiograms (Fig. 2) illustrate representative
basal levels of hippocampal G protein activation (left column)
and G protein activation caused by in vitro treatment with car-
bachol (right column). Comparing left and right columns of
Figures 2B–D shows that the cholinergic agonist carbachol acti-
vated G proteins in all three hippocampal regions (CA1, CA3,
and DG) obtained from rats exposed to the in vivo treatment
conditions of room air, intermittent hypoxia, or sustained hy-
poxia. Levels of G protein activation illustrated by Figure 2 are
expressed quantitatively in Figures 3 and 4 and described
below.
Figures 3A–C summarize the effect of carbachol on [35S]
GTPgS binding as a function of in vivo treatment condition
for each hippocampal region. In the CA1 region (Fig. 3A) and
the CA3 region (Fig. 3B) carbachol significantly (P < 0.01)
increased [35S]GTPgS binding over basal binding values for
the room air, intermittent hypoxia, and sustained hypoxia con-
ditions. Figure 3C shows that within the DG carbachol caused
FIGURE 2. Carbachol activated G proteins in the hippocam-
pus. (A) Coronal atlas plate from Paxinos and Watson (1998) show-
ing the three different measurement areas (CA1, CA3, and DG) in
the rat hippocampus. The boxed area on the left is enlarged on the
right to the same scale as the color-coded autoradiograms in (B),
(C), and (D). Compared to basal levels of G protein activation, car-
bachol significantly activated G proteins following room air (B),
intermittent hypoxia (C), and sustained hypoxia (D) conditions.
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a significant (P < 0.01) increase in G protein activation for the
room air and sustained hypoxia groups. In contrast, carbachol
did not significantly increase [35S]GTPgS binding in the DG
from rats exposed to intermittent hypoxia (Fig. 3C).
DAMGO caused a significant (P < 0.001) activation of hip-
pocampal G proteins compared to basal levels (Figs. 3D–F).
Furthermore, activation of G proteins by DAMGO was always
greater than activation caused by carbachol. In contrast to
carbachol, DAMGO significantly (P < 0.01) increased
[35S]GTPgS binding in the DG for all three in vivo oxygen
conditions (Fig. 3F). Comparison of [35S]GTPgS binding
within each region of the hippocampus showed that carbachol-
and DAMGO-stimulated [35S]GTPgS binding did not signifi-
cantly differ as a function of in vivo O2 condition.
Activation of G Proteins in the CA1, CA3,
and DG
G protein activation by in vivo O2 condition and in vitro
carbachol and DAMGO treatment is plotted in Figure 4 as a
function of hippocampal region. For the room air–carbachol
group (Fig. 4A), repeated measures one-way ANOVA showed
no significant difference in G protein activation as a function
of hippocampal region. For animals treated with intermittent
hypoxia (Fig. 4B), ANOVA revealed a significant difference in
carbachol-stimulated G protein activation (F 5 5.79; df 5 2,
12; P 5 0.02). Tukey-Kramer multiple comparisons test indi-
cated that [35S]GTPgS binding was significantly lower in the
DG than in the CA1. For the different hippocampal areas from
the sustained hypoxia condition (Fig. 4C), ANOVA indicated a
FIGURE 3. G protein activation in CA1, CA3, and DG as a
function of exposure to room air (RA), intermittent hypoxia (IH),
and sustained hypoxia (SH). (A) Relative to basal values (control),
carbachol significantly (*) increased [35S]GTPcS binding in the CA1
region following all three in vivo conditions. (B) Carbachol-stimu-
lated activation of G proteins in the CA3 was also significantly (*)
increased compared to basal binding values for room air, intermittent
hypoxia, and sustained hypoxia. (C) G protein activation by car-
bachol in the DG showed a significant (*) increase in room air and
sustained hypoxia treated animals, but not for rats exposed to inter-
mittent hypoxia. DAMGO significantly (*) increased [35S]GTPcS
binding over basal binding values in the CA1, CA3, and DG (D–F)
for all three in vivo treatments. Hippocampal G proteins were signifi-
cantly activated by carbachol and DAMGO, and ANOVA showed
that there was no difference between any of the black bars (carbachol)
and gray bars (DAMGO), respectively.
FIGURE 4. Carbachol- and DAMGO-stimulated G protein
activation as a function of hippocampal region for each of the
three in vivo treatment conditions. (A) Rats exposed to room air
(RA) showed no significant differences in carbachol-stimulated
[35S]GTPcS binding levels between CA1, CA3, and DG. (B) Ani-
mals exposed to intermittent hypoxia (IH) revealed significantly (*)
lower G protein activation in the DG than in the CA1. (C) Rats
exposed to sustained hypoxia (SH) also displayed a significantly (*)
lower activation of G proteins in the DG than in the CA1 region.
Common to all treatment conditions, the DG revealed a lower
level of G protein activation by carbachol. (D–F) DAMGO-stimu-
lated [35S]GTPcS binding showed no significant difference across
hippocampal regions. Within CA1 and within DG carbachol acti-
vation of G proteins varied as a function of hypoxic treatment.
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region-specific difference in G protein activation (F 5 4.44; df
5 2, 10; P 5 0.05). A significantly lower [35S]GTPgS binding
level for DG compared to CA1 was confirmed by a Tukey-
Kramer multiple comparisons test. In contrast to the carbachol
results, DAMGO-stimulated G protein activation did not show
any significant differences when analyzed as a function of hip-
pocampal regions (Figs. 4D–F).
DISCUSSION
Carbachol Differentially Activated G Proteins
in CA1, CA3, and DG
The present finding that the cholinergic agonist carbachol
significantly increased G protein activation in rat hippocampus
(Figs. 2 and 3) is consistent with the significant increases in
[35S]GTPgS binding in the vertical and horizontal limbs of the
diagonal band of Broca, medial and lateral septum, and nucleus
basalis/substantia innominata caused by carbachol (Douglas
et al., 2004). The G protein data agree also with the long-
standing hypothesis that cholinergic neurotransmission plays a
major role in hippocampal function (Deutsch, 1971).
Cholinergic activation of G proteins varied significantly
across different regions of the hippocampus (Fig. 4). The dif-
ferences in G protein activation between DG and CA1 were
small but statistically significant (Figs. 4B,C). Even small
changes in cholinergic signaling can be physiologically relevant.
For example, the hippocampus shares reciprocal connections
with the prefrontal cortex (Beebe and Gozal, 2002) where even
a 15% increase in acetylcholine (ACh) release causes a physio-
logically significant activation of the electroencephalogram
(Douglas et al., 2002).
The Figure 4 data show that intermittent hypoxia and sustained
hypoxia caused significantly lower carbachol-stimulated G protein
activation in the DG than in the CA1. The present data do not
address the mechanisms causing the lower level of G protein acti-
vation in DG. This result is of interest in view of the continuous
neurogenesis in the DG (Zhu et al., 2005; Christie and Cameron,
2006; Wiskott et al., 2006). The cyclic AMP response element
binding protein (CREB) is critical for neurogenesis and hippocam-
pal CREB can be modulated by hypoxia (Gozal et al., 2003). There
might also be fewer muscarinic cholinergic receptors in the DG.
The decreased G protein activation in DG associated with hypoxia
(Fig. 4) is consistent with previous studies showing that hypoxia
disrupts rat sleep (Hamrahi et al., 2001) and with the finding that
sleep deprivation causes decreased cell proliferation in rat DG
(Guzmán-Marı́n et al., 2003).
Hypoxia Did Not Alter Opioid-Induced
Activation of Hippocampal G proteins
Mu opioid receptors, similar to muscarinic cholinergic recep-
tors, are coupled to G proteins and can be visualized using the
[35S]GTPgS assay (Sim et al., 1995; Capece et al., 1998b).
The significant increase in [35S]GTPgS caused by DAMGO
(Figs. 3D–F) provides a positive control for the activation of G
proteins by carbachol (Figs. 3A–C). The hypothesis that hy-
poxia alters DAMGO-stimulated G protein activation was
drawn from previous evidence showing that mu opioid receptor
activation of G proteins can change with experience. For exam-
ple, chronic heroin administration causes a 61% decrease in
DAMGO-stimulated [35S]GTPgS binding within hippocampus
(Sim-Selley et al., 2000). The current results did not support
the hypothesis that intermittent or sustained hypoxia altered
activation of hippocampal G proteins by DAMGO.
Acetylcholine, Sleep, and Hippocampal Function
There is compelling evidence that ACh contributes to hippo-
campal-dependent learning and memory (Hasselmo and
Schnell, 1994; Vizi and Kiss, 1998; Hasselmo, 1999; Hasselmo
and McClelland, 1999; Rouse et al., 1999; van der Zee and
Luiten, 1999; Rogers and Kesner, 2003) and ACh levels in the
hippocampus increase during memory consolidation (Power
et al., 2003). The view that sleep contributes to memory con-
solidation (Smith, 1985, 1996; Stickgold et al., 2001; Staba
et al., 2002; Datta et al., 2004; Walker and Stickgold, 2006) is
directly relevant to the current focus on cholinergic activation
of hippocampal G proteins. Cholinergic neurotransmission is
involved in generating rapid eye movement (REM) sleep (Lydic
and Baghdoyan, 2005), hypoxia disrupts REM sleep in human
(Ryan and Bradley, 2005) and rat (Hamrahi et al., 2001), and
ACh release in the hippocampus increases during REM sleep
(Marrosu et al., 1995). Basal forebrain neurons provide ACh to
the hippocampus and ACh release in the basal forebrain is
maximal during the REM phase of sleep (Vazquez and Bagh-
doyan, 2001). A memory consolidating role for sleep is also
consistent with electrophysiological data from rat (Wilson and
McNaughton, 1994) and human (Staba et al., 2002) docu-
menting hippocampal CA1 place cell firing patterns during
sleep that replicate discharge sequences previously recorded dur-
ing wakefulness. In contrast to sleep facilitating learning, sleep
deprivation leads to impaired executive control and poor per-
formance on vigilance tasks (Decary et al., 2000; Horstmann
et al., 2000). In rat, sleep deprivation impairs hippocampal-
mediated contextual learning (Ruskin et al., 2004) and selective
REM sleep deprivation impairs learning of a spatial naviga-
tional task (Bjorness et al., 2005).
Limitations and Conclusions
The [35S]GTPgS assay was limited to a single concentration
of carbachol (1 mM) demonstrated by previous studies to be
ideal for detecting G proteins activated by muscarinic choliner-
gic receptors (Capece et al., 1998b; DeMarco et al., 2003;
Douglas et al., 2004). Likewise, the present study used a single
concentration of DAMGO (3 lM), shown previously to acti-
vate G proteins by mu opioid receptors (Capece et al., 1998b;
DeMarco et al., 2003). There are no purely subtype selective
muscarinic agonists and the present study permits no conclu-
sions regarding subtypes of muscarinic cholinergic receptors
mediating the response to carbachol. The exposure to hypoxia
in the present study was limited to a single time interval of 14
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days. The ability of hypoxia to modulate hippocampal G pro-
tein activation may vary as a function of duration of hypoxic
exposure. There are further limitations in the inability of the
present study to specify the type of G proteins activated by
carbachol or DAMGO. In general, the kinetics of the
[35S]GTPgS assay favor activation of inhibitory G proteins
(Harrison and Traynor, 2003; Bernard et al., 2005, 2006).
In spite of these limitations, the [35S]GTPgS assay has two
major advantages for studies of hippocampus (Sim-Selley et al.,
2000; Hong and Werling, 2001). First, this assay provides the
unique ability to localize G proteins while preserving brain
anatomy (Harrison and Traynor, 2003; Bernard et al., 2005).
Thus, the colorized autoradiograms of Figure 2 precisely local-
ize activated G proteins within the CA1, CA3, and DG regions
of rat hippocampus. Second, by subtracting nonspecific binding
from total binding, the assay provides a quantitative measure of
specific [35S]GTPgS binding (Figs. 3 and 4). These two features
made the [35S]GTPgS assay ideal for testing the hypothesis that
hypoxia alters G protein activation in the hippocampus.
In conclusion, three novel findings emerge from this study.
First, compared to basal levels of G protein activation, the cho-
linergic agonist carbachol and the mu opioid agonist DAMGO
significantly activated G proteins in the CA1, CA3, and the
DG regions of the hippocampus. Second, the magnitude of G
protein activation by DAMGO was greater than activation
caused by carbachol, and G protein activation by DAMGO
was not altered by hypoxia. Third, quantifying agonist activa-
tion of G proteins as a function of hippocampal region showed
that intermittent hypoxia and sustained hypoxia caused signifi-
cantly lower levels of G protein activation by carbachol in the
DG than in CA1. These results suggest the potential for hy-
poxia to alter hippocampal function by blunting the cholinergic
activation of G proteins within the DG.
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